206 related articles for article (PubMed ID: 36826131)
1. An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer.
Yanagisawa T; Rajwa P; Kawada T; Bekku K; Laukhtina E; Deimling MV; Majdoub M; Chlosta M; Karakiewicz PI; Heidenreich A; Kimura T; Shariat SF
Curr Oncol; 2023 Feb; 30(2):2194-2216. PubMed ID: 36826131
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis.
Chung DY; Kang DH; Jung HD; Lee JY; Kim DK; Ha JS; Jeon J; Cho KS
Investig Clin Urol; 2023 May; 64(3):242-254. PubMed ID: 37341004
[TBL] [Abstract][Full Text] [Related]
4. Role of radical prostatectomy in metastatic prostate cancer: A review.
Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive radical prostatectomy versus systemic therapy and radiation therapy in metastatic prostate cancer: A systematic review and meta-analysis.
Shemshaki H; Al-Mamari SA; Geelani IA; Kumar S
Urologia; 2022 Feb; 89(1):16-30. PubMed ID: 34355602
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
Mathieu R; Korn SM; Bensalah K; Kramer G; Shariat SF
World J Urol; 2017 Apr; 35(4):567-577. PubMed ID: 27502935
[TBL] [Abstract][Full Text] [Related]
7. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
[TBL] [Abstract][Full Text] [Related]
8. The role of cytoreductive radical prostatectomy and lymph node dissection in bone-metastatic prostate cancer: A population-based study.
Zhai T; Ma J; Liu Y; Li H; Peng Y; Guo W; Jia J; Wu X; Jiang H; Tian J; Wang D
Cancer Med; 2023 Aug; 12(16):16697-16706. PubMed ID: 37366247
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive prostatectomy: what is the evidence? A systematic review.
Albisinni S; Aoun F; Diamand R; Al-Hajj Obeid W; Porpiglia F; Roumeguère T; De Nunzio C
Minerva Urol Nefrol; 2019 Feb; 71(1):1-8. PubMed ID: 30547907
[TBL] [Abstract][Full Text] [Related]
10. The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry.
Lumen N; De Bleser E; Buelens S; Verla W; Poelaert F; Claeys W; Fonteyne V; Verbeke S; Villeirs G; De Man K; Rottey S; Van Praet C; Decaestecker K; Ost P;
Eur Urol Open Sci; 2021 Jul; 29():68-76. PubMed ID: 34337536
[TBL] [Abstract][Full Text] [Related]
11. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports.
Rajwa P; Zattoni F; Maggi M; Marra G; Kroyer P; Shariat SF; Briganti A; Montorsi F; Heidegger I; Gandaglia G;
Eur Urol Focus; 2023 Jul; 9(4):637-641. PubMed ID: 36697321
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis.
Mao Y; Hu M; Yang G; Gao E; Xu W
World J Surg Oncol; 2022 Aug; 20(1):255. PubMed ID: 35945562
[TBL] [Abstract][Full Text] [Related]
14. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial.
Mandel PC; Huland H; Tiebel A; Haese A; Salomon G; Budäus L; Tilki D; Chun F; Heinzer H; Graefen M; Pantel K; Riethdorf S; Steuber T
Eur Urol Focus; 2021 Jan; 7(1):55-62. PubMed ID: 31178293
[TBL] [Abstract][Full Text] [Related]
15. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
Bayne CE; Williams SB; Cooperberg MR; Gleave ME; Graefen M; Montorsi F; Novara G; Smaldone MC; Sooriakumaran P; Wiklund PN; Chapin BF
Eur Urol; 2016 May; 69(5):775-87. PubMed ID: 26003223
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive and Palliative Radical Prostatectomy, Extended Lymphadenectomy and Bilateral Orchiectomy in Advanced Prostate Cancer with Oligo and Widespread Bone Metastases: Result of a Feasibility, Our Initial Experience.
Simforoosh N; Dadpour M; Mofid B
Urol J; 2019 May; 16(2):162-167. PubMed ID: 30393838
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of cytoreductive prostatectomy in patients with metastatic disease.
Jaber Y; Reichard CA; Chapin BF
Transl Androl Urol; 2018 Sep; 7(Suppl 4):S505-S513. PubMed ID: 30363448
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Preisser F; Mazzone E; Nazzani S; Bandini M; Tian Z; Marchioni M; Steuber T; Saad F; Montorsi F; Shariat SF; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol; 2018 Dec; 74(6):693-696. PubMed ID: 30037529
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive radical prostatectomy or radiation therapy for metastases prostate cancer: Evidence from meta-analysis.
Peng Z; Huang A
Medicine (Baltimore); 2022 Sep; 101(38):e30671. PubMed ID: 36197186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
